Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis

Abstract

At 3 months, discontinuation of UDCA in patients with PSC causes significant deterioration in liver biochemistry and influences concentrations of bile acid metabolites. A proportion of patients report increased pruritus, but other short-term markers of quality of life are unaffected.